Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
Unveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key Metrics
10:21am, Wednesday, 24'th Apr 2024
Evaluate the expected performance of Qiagen (QGEN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
QIAGEN N.V. to release results for Q1 2024 and hold webcast
09:48am, Tuesday, 09'th Apr 2024
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024.
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
02:26pm, Thursday, 04'th Apr 2024
QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
04:05pm, Wednesday, 03'rd Apr 2024
Novel QIAcuity dPCR PanCancer Kits can detect rare mutations of EGFR and BRAF genes at the same time, while saving sample material, reducing time and cost // New QIAseq Targeted RNA-seq Panel for T-ce
MyBio Are the New Exclusive Partner for QIAGEN in Ireland & Northern Ireland
12:31pm, Wednesday, 27'th Mar 2024
KILKENNY, Ireland--(BUSINESS WIRE)-- #cancerresearch--MyBio Ltd., an award-winning specialist Irish life science distribution partner, announces a new exclusive partnership with QIAGEN, a leading glob
QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access
11:11am, Tuesday, 26'th Mar 2024
With QIAGEN's (QGEN) QIAstat-Dx Analyzer 2.0's integration of remote access, central and regional laboratories may work together efficiently, particularly when it comes to decentralized testing.
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
10:10am, Monday, 25'th Mar 2024
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
Qiagen (QGEN) Up 1.1% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 07'th Mar 2024
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock?
QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base
09:41am, Monday, 04'th Mar 2024
QIAGEN (QGEN) introduces a Biomedical KB-AI knowledge base to accelerate data-driven drug discovery.
QIAGEN (QGEN) Earns Notable Recognitions in Sustainability
10:10am, Monday, 19'th Feb 2024
QIAGEN (QGEN) achieves the ACT Label for new eco-friendly QIAwave products and the first My Green Lab Platinum certification.
Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript
04:55am, Sunday, 11'th Feb 2024
Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript
QIAGEN (QGEN) Q4 Earnings Miss, Operating Margin Expands
08:21am, Wednesday, 07'th Feb 2024
QIAGEN's (QGEN) fourth-quarter performance reflects impressive CER sales growth and solid profitability.
Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say
09:01pm, Tuesday, 06'th Feb 2024
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Stree
QIAGEN (QGEN) Forges Alliance to Advance Microbiome Sciences
08:36am, Wednesday, 31'st Jan 2024
QIAGEN (QGEN) announces a first-in-kind collaboration with Penn State University to help shape research, education and outreach in microbiomes.
QIAGEN (QGEN) Wins FDA Clearance for NeuMoDx CT/NG Assay
09:47am, Friday, 12'th Jan 2024
QIAGEN (QGEN) receives FDA clearance for the NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 versions of the integrated PCR-based clinical molecular testing system.
